Full Professor (Level III) to lead a research line in the field of cerebrovascular disease*
7 hours ago
Madrid
Full Professor (Level III) to lead a research line in the field of cerebrovascular disease* • Temporary position under the Spanish employment category “Contrato de Investigador/a Distinguido/a” The Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) (CNIC) is seaking an outstanding Principal Investigator at the career stage in which he/she has consolidated an independent research team, to join the institution as Full Professor III in the field of cerebrovascular disease. As group leader, the selected candidate will be responsible for developing the laboratory’s research lines. In addition, she/he will be expected to secure extramural funding from highly competitive national and international funding sources to support these projects and to publish scientific results in high-impact international journals in the fields of cardiovascular research, general medicine, and/or multidisciplinary sciences. The selected candidate will supervise all members of the team, including research and technical staff. Additional responsibilities include coordination and management tasks requested by CNIC leadership, including participation in committees, and support in other institutional needs that may arise. Mandatory requirements: PhD in the field of Life Sciences (Biology, Chemistry, Medicine, etc.) At least 10 years of experience as Group Leader in an internationally recognized research center in the cardiovascular field (6 years and 8 months for individuals with a disability degree exceeding 66%, and 8 years and 4 months for individuals with a disability degree exceeding 33%). Excellent recent scientific publication record, fulfilling at least one of the following criteria (bibliometric parameters according to Web of Science/Journal Citation Reports): ≥ 6 original articles as corresponding author (or co-corresponding author) published in the last 5 years (i.e., since August 2021) in journals ranked in the first decile of their field (according to the year of publication). ≥1 original articles as corresponding author (or co-corresponding author) published in the last 5 years (i.e., since August 2021) in journals ranked in the TOP3 of their field (according to the year of publication). ≥1 original articles as corresponding author (or co-corresponding author) published in the last 5 years (i.e., since August 2021) classified as Highly Cited Paper according to Web of Science. 1. Experience as Principal Investigator and/or Coordinator of research grants obtained from international funding sources (funding agency based outside Spain) during the last 5 years (i.e., since August 2021). 5. Main research focus aligned with the field of cerebrovascular disease Valuable requirements: C1. Scientific production: publications as corresponding author (or co-corresponding author) in first decile journals during the last 5 years. C2. Fundraising (international): Projects obtained from international funding sources (funding agency based outside Spain) as Principal Investigator or Coordinator during the last 5 years.The CV must specify for each project the role of the candidate, amount granted, funding period, and funding agency. C3. Fundraising (national): Projects obtained from national funding sources as Principal Investigator or Coordinator during the last 5 years. The CV must specify for each project the role of the candidate, amount granted, funding period, and funding agency. C4. International recognition: Participation in international committees, advisory boards, grant evaluation panels, invited lectures at major international meetings, and editorial boards during the last 5 years (i.e., since August 2021). C5. Training and mentoring: Experience mentoring young researchers (PhD students, postdoctoral researchers, MD trainees, etc), and participation in training activities during the last 5 years (i.e., since August 2021).Evaluation will consider number of PhD students and postdoctoral fellows supervised, career progression of supervised researchers (which should be indicated in the CV), and involvement in training activities. C6. Impact on society: Translation of research discoveries into clinical practice, patents, industrial collaborations, and societal impact during the last 5 years (i.e., since August 2021).This criterion will be valued according to the relevance of research for society/patients, number and relevance of patents, and research interactions with industry. C7. Cerebrovascular focus: Scientific publications and research projects led as corresponding author (or co-corresponding author) or Principal Investigator suring the last 5 years (i.e., since August 2021) specifically focused on cerebrovascular disease. C8. Gender underrepresentation. Positive action criterion in accordance with Action S1 of the 2021-2024 Equality Plan, addressing underrepresentation by category. We offer: A research position in a consolidated research centre of international scientific relevance. Access to state-of-the art infrastructures and advanced technologies. Integration into an excellent scientific environment. Immediate incorporation, adaptable to the candidate’s circumstances Selection Plan The candidate obtaining the highest score will be selected, provided the final score exceeds 85 points (according to Evaluation Criteria C1-C8). Evaluation Commission: The evaluation commission will consist of 3 members of CNIC’s Scientific Advisory Board, and two members of CNIC’s Scientific Direction. "In the event that any evaluator is unavailable, an alternate evaluator will be appointed" The CNIC guarantees, within its field of action, the principle of equal access to employment, and does not permit direct or indirect discrimination, based on origin (including racial or ethnic origin), sex, age, marital status, religion or beliefs, political opinion, sexual orientation or identity, gender expression, sexual characteristics, trade union membership, social status, language within the State, or disability, provided that candidates are fit to perform the duties of the position. By participating in the selection process, candidates agree that their data may appear in the public resolutions of the recruitment process. These resolutions (provisional list of admitted and excluded, final list of admitted and excluded candidates, and final selection resolution) are published on the CNIC website. In accordance with Regulation (EU) 2016/679 (GDPR) and Ley Orgánica 3/2018, de 5 de diciembre, de Protección de Datos Personales y garantía de los derechos digitales (LOPD-GDD), your personal data will be processed by CNIC solely for the purpose of managing your application and retained for the duration of the selection process. You may exercise your data protection rights by contacting the CNIC Data Protection Officer ( protecciondedatos@cnic.es ) Evaluation Criteria: C1. Scientific production: publications as corresponding author (or co-corresponding author) in first decile journals during the last 5 years (i.e., date of publication since August 2021). Greater value will be given to original research articles. Only published papers (or papers available online ahead of print) will be considered. The CV must include the complete list of authors, journal´s impact factor, and ranking in the year of publication for each article. 30% C2. Fundraising (international): Projects obtained from international funding sources (funding agency based outside Spain) as Principal Investigator or Coordinator during the last 5 years (i.e., active projects in August 2021 onwards).The CV must specify for each project the role of the candidate, amount granted, funding period, and funding agency. 25% C3. Fundraising (national): Projects obtained from national funding sources as Principal Investigator or Coordinator during the last 5 years (i.e. active projects in August 2021 onwards).Evaluation will consider funding source relevance, amount granted, and number of projects. The CV must specify for each project the role of the candidate, amount granted, funding period, and funding agency. 10% C4. International recognition: Participation in international committees, advisory boards, grant evaluation panels, invited lectures at major international meetings, and editorial boards during the last 5 years (i.e., since August 2021). 10% C5. Training and mentoring: Experience mentoring young researchers (PhD students, postdoctoral researchers, MD trainees, etc), and participation in training activities during the last 5 years (i.e., since August 2021).Evaluation will consider number of PhD students and postdoctoral fellows supervised, career progression of supervised researchers (which should be indicated in the CV), and involvement in training activities. 5% C6. Impact on society: Translation of research discoveries into clinical practice, patents, industrial collaborations, and societal impact during the last 5 years (i.e., since August 2021).This criterion will be valued according to the relevance of research for society/patients, number and relevance of patents, and research interactions with industry. 5% C7. Cerebrovascular focus: Scientific publications and research projects led as corresponding author (or co-corresponding author) or Principal Investigator suring the last 5 years (i.e., since August 2021) specifically focused on cerebrovascular disease. 10% C8. Gender underrepresentation. Positive action criterion in accordance with Action S1 of the 2021-2024 Equality Plan, addressing underrepresentation by category. 5% C1 - Scientific production - 30% C4 - International recognition - 10% C5 - Training and mentoring - 5% C6 - Impact on society - 5% C7 - Cerebrovascular focus - 10% #J-18808-Ljbffr